DJ Biogen Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slid 1.05% to $196.58 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.08% to 7,500.58 and the Dow Jones Industrial Average rising 0.14% to 51,564.70.
Biogen Inc. closed 4.56% below its 52-week high of $205.97, which the company achieved on May 13th.
Despite its losses, the stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 2.48% to $228.39, Pfizer Inc. $(PFE)$ fell 2.74% to $25.21, and AbbVie Inc. $(ABBV)$ fell 2.14% to $216.49.
Trading volume (1.7 M) eclipsed its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 18, 2026 16:59 ET (20:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments